Trial intelligence / Profile preview

Hyaluronic Acid for Infra-bony Defects in Chronic Periodontitis

NCT02170857Completed

Sponsor
Damascus University
Start
Jun 2014
Primary completion
Feb 2016
Modality
Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, open-label trial of hyaluronic acid in chronic periodontitis, sponsored by Damascus University. Primary endpoints: Clinical Attachment Loss at 12 months and Vertical bone fill at 12 months. Started Jun 2014; status: completed.

02

Drugs

hyaluronic acid
03

Conditions

chronic periodontitis

Beyond the preview

Go deeper on NCT02170857.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02170857.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call